Previous studies have identified two signaling interactions regulating cardiac myogenesis in avians, a hypoblast-derived signal acting on epiblast and mediated by activin or a related molecule and an endoderm-derived signal acting on mesoderm and involving BMP-2. In this study, experiments were designed to investigate the temporal relationship between these signaling events and the potential role of other TGF␤ superfamily members in regulating early steps of heart muscle development. We find that while activin or TGF␤ can potently induce cardiac myogenesis in pregastrula epiblast, they show no capacity to convert noncardiogenic mesoderm toward a myocardial phenotype. Conversely, BMP-2 or BMP-4, in combination with FGF-4, can readily induce cardiac myocyte formation in posterior mesoderm, but shows no capacity to induce cardiac myogenesis in epiblast cells. Activin/TGF␤ and BMP-2/BMP-4 therefore have distinct and reciprocal cardiac-inducing capacities that mimic the tissues in which they are expressed, the pregastrula hypoblast and anterior lateral endoderm, respectively. Experiments with noggin and follistatin provide additional evidence indicating that BMP signaling lies downstream of an activin/TGF␤ signal in the cardiac myogenesis pathway. In contrast to the cardiogenicinducing capacities of BMP-2/BMP-4 in mesoderm, however, we find that BMP-2 or BMP-4 inhibits cardiac myogenesis prior to stage 3, demonstrating multiple roles for BMPs in mesoderm induction. These and other published studies suggest a signaling cascade in which a hypoblast-derived activin/TGF␤ signal is required prior to and during early stages of gastrulation, regulated both spatially and temporally by an interplay between BMPs and their antagonists. Later cardiogenic signals arising from endoderm, and perhaps transiently from ectoderm, and mediated in part by BMPs, act on emerging mesoderm within cardiogenic regions to activate or enhance expression of cardiogenic genes such as GATA and cNkx family members, leading to cardiac myocyte differentiation.
INTRODUCTION
Cells that contribute to the avian heart are found prior to gastrulation within the posterior half of the epiblast (Rawles, 1943; Hatada and Stern, 1994) . These cells involute early during gastrulation and are found within a broad region of the primitive streak caudal to Hensen's node (Garcia-Martinez and Schoenwolf, 1993) . Specification of premyocardial cells commences while the cells are within the streak (Yatskievych et al., 1997) and continues through late gastrulation as mesodermal premyocardial cells migrate out of the streak and form bilateral precardiac regions on either side of the anterior midline (Gonzalez-Sanchez and Bader, 1990; Antin et al., 1994; Montgomery et al., 1994; Gannon and Bader, 1995) . Cell migration, along with flexion and folding of the embryo, brings the presumptive heart primordia together where they fuse to form the primitive heart tube, composed of an outer myocardium and an inner endocardium (DeHaan, 1963a,b; Rosenquist, 1966) . Differentiation of cardiac myocytes occurs as the heart tube forms, such that by the time fusion is completed the heart is a functional contractile organ.
Many studies have sought to elucidate tissue interactions required for the induction of myocardial cell lineages. In amphibians, roles in cardiac lineage specification have been identified for both the organizer region and the deep dorsoanterior endoderm (Sater and Jacobson, 1990; Nascone and Mercola, 1995) . In birds, two cell layers have been shown to possess cardiogenic-inducing capacities, the pregastrula hypoblast (Yatskievych et al., 1997) and the anterior lateral (precardiac) endoderm (Orts-Llorca, 1963; Orts-Llorca and Gil, 1965; Schultheiss et al., 1995; Sugi and Lough, 1995; Yatskievych et al., 1997) . Inducing capacities of these two cell layers are not equivalent, however, as the hypoblast can potently induce cardiac myogenesis in responsive epiblast but only weakly in mesodermal cells, whereas the endoderm can readily convert nonprecardiac mesoderm to a cardiac phenotype but has no ability to induce heart development in epiblast cells (Schultheiss et al., 1995; Yatskievych et al., 1997) .
Recent studies have identified molecules that may be responsible for these inductive signals. Activin mRNA is present in the chick pregastrula hypoblast (Mitrani et al., 1990) , and activin can substitute for the hypoblast to induce myocardial cell formation in quail posterior pregastrula epiblast (Yatskievych et al., 1997) . High concentrations of activin can also induce cardiac myogenesis in the amphibian animal cap assay (Logan and Mohun, 1993) . TGF␤ proteins have been detected in the marginal zone region of the chick pregastrula embryo and in some cells of the hypoblast (Sanders et al., 1993 (Sanders et al., , 1994 . Although TGF␤ have been shown to induce some mesodermal cell types in amphibian animal caps (Rosa et al., 1988) , the potential role of TGF␤ molecules in early steps of cardiac myogenesis in amniotes has not been examined.
Anterior lateral endoderm secretes a variety of signaling molecules. Among these, growth factors such as insulin, insulin-like growth factor II, activin, and fibroblast growth factors (FGFs) appear to promote survival and replication of specified premyocardial cells and differentiating myocytes Parlow et al., 1991; Sugi et al., 1993; Sugi and Lough, 1995; Antin et al., 1996; Zhu et al., 1996) , while bone morphogenetic proteins (BMPs) appear to play an inductive role. At mid-to late gastrula stages, BMP-4 is expressed in a ring of ectoderm surrounding the future neural plate that is adjacent to precardiac mesoderm; by stage 6, precardiac mesoderm is in contact with BMP-2-expressing anterior lateral endoderm (Schultheiss et al., 1997; Streit et al., 1998) . Localized application of BMP-2 to the anterior medial region of stage 6 embryos can induce local mesodermal expression of cNkx2-5 and GATA-4, and treatment of explanted stage 6 anterior medial (noncardiogenic) mesendoderm with either BMP-2 or BMP-4 can induce full cardiac differentiation (Schultheiss et al., 1997; Andrée et al., 1998) . While BMP-2 alone cannot induce posterior lateral mesoderm to become cardiogenic, a combination of BMP-2 plus FGF-4 is sufficient to mimic anterior lateral endoderm in converting posterior mesoderm to a myocardial cell fate . The ability of noggin, a natural BMP antagonist, to inhibit differentiation of premyocardial cells further indicates that BMPs are required for a late step in the cardiac myogenesis pathway (Schultheiss et al., 1997) .
The findings summarized above suggest that cardiac myogenesis is regulated by two temporally distinct signaling events, an early signal derived from hypoblast acting on epiblast and mediated by activin and/or TGF␤ and a later endoderm-derived signal acting on mesoderm involving BMPs. In the present study, experiments were performed to test this possibility. We find that activin/TGF␤ and BMP-2/BMP-4 have distinct and reciprocal cardiac-inducing capacities that mimic the tissues in which they are expressed, the pregastrula hypoblast and the anterior lateral endoderm, respectively. Noggin can block activin-mediated induction of cardiac myogenesis in epiblast, providing additional evidence that BMP signaling lies downstream of activin/ TGF␤ signaling in the cardiac myogenesis pathway. We also find that BMP-2-or BMP-4 can inhibit cardiac myogenesis prior to gastrulation, demonstrating multiple roles for BMP-2/BMP-4 in mesoderm development.
MATERIALS AND METHODS

Embryo Explantation and Culture
Embryos were removed from fertile chick eggs (Gallus domesticus; Rosemary Farms, Santa Maria, CA, or SPAFAS, Inc., Preston, CT) following 0 -24 h of incubation at 37°C in a humidified incubator and staged according to Eyal-Giladi and Kochav (1976) for pregastrula stages (XI-XIV) and according to Hamburger and Hamilton (1951) for stages from the beginning of gastrulation (stage 2) onward. Embryos were removed from the egg, placed in 123 mM NaCl, and cleaned of adhering yolk using an eyebrow hair brush. Explantation of stage XI-XIV intact posterior regions or posterior region epiblast and heart-forming regions of stage 2-6 embryos was performed as described (Yatskievych et al., 1997) . Explants were transferred to a fibronectin-coated Lab Tek chamber slide (Naperville, IL) and cultured in defined medium (75% DMEM:25% McCoy's medium, supplemented with 10 Ϫ7 M dexamethasone and 50 g/ml gentamycin) in a humidified incubator at 37°C and 7% CO 2 for 72 h, unless otherwise noted.
Growth Factors and Antagonists
Follistatin (National Hormone and Pituitary Program, Bethesda, MD) was prepared as a 1 mg/ml stock in 0.1 N HOAc and diluted to working concentrations in defined medium plus 0.25-0.5 mg/ml bovine serum albumin (BSA; Sigma, St. Louis, MO). Conditioned medium was harvested from parental CHO cells or CHO cells stably expressing Xenopus noggin (Smith and Harland, 1992) ; CHO lines were kindly provided by R. Harland (University of California, Berkeley). Noggin-containing or control conditioned media were each mixed 1:1 with defined medium supplemented with BSA to a final concentration of 0.25 mg/ml. Human recombinant activin A (Genentech, South San Francisco, CA, and National Hormone and Pituitary Program), porcine TGF␤-1 (R&D Research, Minneapolis, MN), human recombinant BMP-2 and BMP-4 (Genetics Institute, Cambridge, MA), and human recombinant FGF-4 (R&D Research) were diluted to working concentrations in defined medium plus 0.25-0.5 mg/ml BSA. Solutions of growth factors and antagonists were prepared immediately prior to use. For some experiments, BMP and FGF-4 concentrations were chosen to be consistent with previously published work .
Immunofluorescence
A detailed study has previously demonstrated that explants from the posterior region of pregastrula chick or quail embryos, or pregastrula epiblast treated with activin, give rise to cardiac, but not skeletal muscle cells, during the first 72 h of culture (Yatskievych et al., 1997) . These findings enabled to us employ a rapid immunofluorescence screen using an antibody against muscle myosin heavy chain to assay for the presence of cardiac myocytes. For this analysis, explants were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min at room temperature, then incubated in PBS plus 0.2% Triton X-100 and 0.02% sodium azide for 30 -45 min at room temperature. Explants were processed for immunofluorescence using anti-LMM (anti-light meromyosin; a gift from Howard Holtzer, University of Pennsylvania, Philadelphia), a fluorescein-conjugated rabbit antibody that is specific for striated muscle-specific myosin heavy chain isoforms (Antin et al., 1994) , and DAPI (Sigma) as described (Yatskievych et al., 1997) . Explants were scored as positive for cardiac myocytes when containing at least one cluster of 4 or more brightly fluorescing anti-LMMstained cells. Positive explants generally contained 15-200 contiguous anti-LMM-positive cells arranged in one or more muscular regions. Myocardial cells within many cultures exhibited spontaneous rhythmic contractions prior to fixation. Statistical analyses were conducted as pairwise comparisons of proportions using a modified z test with a pooled estimate of the standard error.
RESULTS
Activin/TGF␤ and BMP-2/BMP-4 Have Distinct Cardiogenic-Inductive Capacities Which Mimic the Pregastrula Hypoblast and the Anterior Lateral Endoderm, Respectively
To more fully investigate the roles of TGF␤ family members in regulating cardiac myogenesis, the abilities of several growth factors to induce heart muscle development in either epiblast or noncardiogenic mesoderm were compared. Activin readily induced cardiac myogenesis in chick posterior region epiblast (Figs. 1A and 2A) (Yatskievych et al., 1997) , but showed no ability to induce heart muscle cells in noncardiogenic anterior medial mesoderm (Schultheiss et al., 1997) or posterior lateral mesoderm (Fig. 2B ). TGF␤ proteins can induce dorsal mesoderm from Xenopus animal caps (Rosa et al., 1988) . Since TGF␤ proteins are present within some cells of the pregastrula hypoblast (Sanders et al., 1994) , the ability of TGF␤-1 to substitute for hypoblast to induce cardiac myogenesis within chick posterior epiblast was also tested. Like activin, TGF␤-1 induced the appearance of cardiac myocytes in responsive epiblast in a dose-dependent manner (Fig. 1B) .
Conversely, neither BMP-2 nor BMP-4 was capable of inducing myocardial cell formation in chick pregastrula posterior region epiblast at any dose examined (Fig. 1C) . While BMP-2 and BMP-4 were similarly unable to induce cardiac myogenesis in posterior mesoderm when used alone, heart muscle cells were potently induced when posterior mesoderm was challenged with either molecule in combination with FGF-4 ( Fig. 2B) . BMP-2 or BMP-4 plus FGF-4 was unable to induce cardiac myogenesis above control levels in pregastrula posterior region epiblast ( Fig. 2A) , and activin plus FGF-4 was unable to induce cardiac myogenesis in posterior mesoderm (Fig.  2B) , indicating that the inability of BMPs to mimic the inductive capacity of the hypoblast, or of activin to mimic the inductive capacity of anterior lateral endoderm, is not due to the lack of a synergistic FGF partner. These findings, taken together with previous studies, show that activin/ TGF␤ can induce cardiac myogenesis in epiblast but not in mesoderm, while BMP-2 or BMP-4, alone or in combination with FGF-4, can induce cardiac myogenesis in noncardiogenic mesoderm but not in epiblast.
It is interesting to note that although FGF-4 is incapable of inducing heart muscle formation in gastrula-stage posterior lateral mesoderm ( Fig. 2B) , it is a potent inducer of cardiac myogenesis in pregastrula posterior region epiblast ( Fig. 2A) . Addition of BMP-2 or BMP-4, however, inhibited the heart muscle-inducing capacity of FGF-4. Thus, although BMP-2 and BMP-4 are potent inducers of heart muscle in noncardiogenic mesoderm, they can inhibit cardiac myogenesis in epiblast (see below). The potential role of FGFs in avian mesoderm induction will be detailed elsewhere.
Activin and TGF␤ Can Induce Cardiac Myogenesis in Epiblast Cells That Are Not Normally Fated to Form Heart
As shown above (Figs. 1A and 2A) and previously (Yatskievych et al., 1997) , activin and TGF␤-1 are potent inducers of heart muscle cells in posterior region epiblast. Posterior epiblast contains cells that are fated to form heart (Hatada and Stern, 1994) , however, and thus it is not clear from these experiments whether activin or TGF␤-1 provides a permissive influence or whether these molecules are capable of changing the fate of epiblast cells toward a myocardial phenotype. To address this issue, the ability of activin or TGF␤-1 to induce cardiac myogenesis in epiblast regions not fated to give rise to heart was investigated. Explants from the anterior regions of stage XI-XIV embryos consisting of both epiblast and forming hypoblast, or anterior epiblast alone, failed to form heart muscle cells in culture (Figs. 3A and 3B) (Yatskievych et al., 1997) . In contrast, anterior epiblast explants treated with activin or TGF␤-1 contained cardiac myocytes in 43 (n ϭ 14) and 28% (n ϭ 18) of cases, respectively (versus 0% for untreated controls, n ϭ 20; significant at P Ͻ 0.01; Figs. 3C-3F). Consistent differences in the health or overall number of cells within treated versus untreated explants were not observed, suggesting that observed effects were not due to differences in cell death or proliferation.
Follistatin and Noggin Inhibit Cardiac Myogenesis
To investigate further the involvement of activin and BMP signaling during cardiac myogenesis, chick pregastrula posterior region explants were exposed to follistatin or noggin at progressively later times following explantation. While follistatin can block both BMP and activin signaling, noggin is a specific inhibitor of BMP function (Nakamura et al., 1990; Kogawa et al., 1991; Yamashita et al., 1995; Piccolo et al., 1996; Zimmerman et al., 1996; Fainsod et al., 1997) . Consistent with previous reports (Schultheiss et al., 1997; Yatskievych et al., 1997) , explantation of posterior regions of stage XI-XIV embryos directly into follistatin-or noggin-containing medium inhibited cardiac myogenesis (Figs. 4A and 4B). Addition of follistatin or noggin at progressively later times following explantation resulted in a gradual reappearance of heart muscle cells, the timing of which was distinct for each molecule. Whereas follistatin effectively inhibited cardiac myogenesis only if added prior to 24 h following explantation, control levels of cardiac myogenesis in explants exposed to noggin were not observed until treatment was delayed 36 h (Fig. 4A) , coincident with the onset of cardiac myocyte differentiation (Yatskievych et al., 1997) .
To determine whether the differential time course of sensitivity to follistatin or noggin observed in explant culture reflects changes occurring in vivo, stage 5 or 6 precardiac region mesendoderm was explanted directly into noggin-or follistatin-containing medium and assayed for the presence of differentiated cardiac myocytes after 48 h. As shown in Fig. 4B , noggin, but not follistatin, effectively inhibited cardiac myogenesis in stage 5 precardiac region explants. By stage 6, noggin had FIG. 1. Induction of cardiac myogenesis in posterior region epiblast by activin and TGF␤1. Posterior region epiblast from stage XI-XIV chick embryos was cultured in defined medium plus 0.25-0.5 mg/ml BSA in the presence of increasing amounts of (A) activin, (B) TGF␤-1, or (C) BMP-2 or BMP-4 for 72 h and then scored for the presence of heart muscle cells. Activin and TGF␤-1, but not the BMPs, induced cardiac myogenesis in epiblast in a dose-dependent manner. An asterisk (*) denotes a value significantly different from control (P Ͻ 0.05).
also lost the ability to block cardiac myocyte differentiation, in agreement with Schultheiss et al. (1997) . Thus, both for posterior pregastrula region explants and for explants from heart-forming regions of progressively older embryos, noggin inhibited cardiac myogenesis at a later stage than follistatin under these assay conditions.
BMP Signaling Is Required for Activin-Mediated Induction of Cardiac Myogenesis
To explore the relationship between activin and BMP signaling during cardiac myogenesis further, we asked whether noggin could inhibit induction of cardiac myogenesis by activin in pregastrula posterior region epiblast. As shown in Fig. 5 , whereas 5 ng/ml activin induced the appearance of cardiac myocytes in epiblast cultured in control conditioned medium (40% of treated explants contained cardiac myocytes, n ϭ 20, relative to 0% of cases for untreated controls, n ϭ 15; significant at P Ͻ 0.005), the presence of noggin efficiently blocked the ability of activin to induce myocardial cell formation (only 8% of explants contained cardiac myocytes, n ϭ 25; significantly less than activin treatment alone, P Ͻ 0.005, and not significantly different from untreated controls, P Ͻ 0.05). Again, no significant differences were observed in health or cell number within treated versus untreated explants, indicating that the observed effects were not due to gross changes in cell death or proliferation. Taken with the results showing reciprocal inducing capacities of activin/TGF␤ and BMPs, these findings provide additional strong evidence that inductive BMP signals are required downstream of activin in the cardiac myogenesis pathway.
BMPs Inhibit Cardiac Myogenesis Prior to Stage 3
Results above show that BMP-2 or BMP-4 can inhibit the ability of FGF-4 to induce cardiac myogenesis in posterior epiblast ( Fig. 2A) . To determine whether BMPs could also inhibit activin induction of heart muscle cells, chick pregastrula posterior region epiblast was explanted into medium containing activin plus BMP-2 or BMP-4. As shown in Fig. 2A , either BMP-2 or BMP-4 abolished the ability of activin to induce the appearance of heart muscle cells. When intact posterior region explants consisting of epiblast plus hypoblast were cultured in the presence of BMP-2 or BMP-4, the appearance of differentiated cardiac myocytes was also inhibited (Fig. 6) . Inhibition of cardiac myogenesis was also observed in posterior region explants following addition of fetal bovine serum to the culture medium (data not shown).
To investigate the timing of the BMP inhibitory signal, intact posterior region explants consisting of epiblast plus hypoblast were exposed to BMP-2 or BMP-4 at progressively later times following explantation. Both BMP-2 and BMP-4 potently inhibited the incidence of cardiac myogenesis only if added within 12 to 18 h of incubation (Fig 6A) , even though differentiated cardiac myocytes are not observed until 32-36 h in control cultures (Yatskievych et al., 1997) . To determine if the
FIG. 2. Induction of cardiac myogenesis in mesoderm. (A)
Posterior region epiblast from stage XI-XIV chick blastoderms or (B) posterior lateral mesoderm from stage 5 chick embryos was explanted into defined medium plus BSA with 5 ng/ml activin, 100 ng/ml BMP-2, 100 ng/ml BMP-4, or 100 ng/ml FGF-4 either alone or in various combinations. BMP-2 or BMP-4 in combination with FGF-4 can induce cardiac myogenesis in posterior lateral mesoderm, but cannot induce pregastrula epiblast alone or in combination. Activin alone can induce cardiac myocyte formation in epiblast, but not in mesoderm, either alone or in combination with FGF-4. Either BMP-2 or BMP-4 can block induction of epiblast by FGF-4 or activin. An asterisk (*) denotes a value significantly different from control (P Ͻ 0.05).
loss of responsiveness to BMP inhibition reflects changes occurring in vivo, heart-forming regions from progressively older gastrula stage embryos were explanted directly into medium containing BMP-2 or BMP-4. Since the time course in vitro indicated a narrow early window of sensitivity, the heart-forming region of the primitive streak of early (stage 2) and mid-(stage 3) gastrula stage embryos, as well as mesendoderm explants from late (stage 5) gastrula stage embryos, was explanted. As shown in Fig. 6B , the sensitivity to BMP inhibition is lost in the early to midgastrula stages, the time at which endoderm and mesoderm are first arising from epiblast cells involuting into the primitive streak. Collectively, these results indicate that BMP-2 and BMP-4 can inhibit the ability of activin, FGF-4, or the hypoblast to induce heart muscle cell development in epiblast prior to stage 3. After this time, BMPs provide a positive signal that is required for progression to differentiated myocardium.
DISCUSSION
We have previously described an avian explant assay for investigating signaling interactions regulating myocardial cell development (Yatskievych et al., 1997) . Using explants from the posterior region of stage XI-XIV chick and quail embryos, it was shown that a signal(s) from the hypoblast is necessary for the appearance of cardiac myocytes, that activin can substitute for the hypoblast to induce cardiac myogenesis, and that the inducing capacities of the pregastrula hypoblast and late gastrula anterior lateral endoderm are qualitatively distinct. Several studies have shown that BMP-2 plays an important role in mediating the cardiacinducing capacity of anterior lateral endoderm Schultheiss et al., 1997; Andrée et al., 1998) .
In the present study, we have shown that activin/TGF␤ and BMP-2 have distinct and reciprocal inducing capacities that mimic the cell layers in which they are expressed, the hypoblast and anterior lateral endoderm, respectively. Consistent with these inducing capacities, timing experiments using noggin and follistatin indicate that activin/TGF␤ signaling lies upstream of BMP signaling in the cardiac myogenesis pathway. Additionally, we find that BMP-2 or BMP-4 can inhibit an early step in cardiac myogenesis prior to stage 3, showing that BMPs have an early inhibitory and later inductive role in heart muscle development.
FIG. 4. Inhibition of cardiac myogenesis by follistatin and noggin. (A)
Stage XI-XIV posterior region explants from chick blastoderms were explanted in control medium. Treatment was initiated at varying times following explantation by replacement of control medium with medium containing 100 ng/ml follistatin or conditioned medium containing noggin, and the incidence of cardiac myogenesis was determined following 72 h of culture in all cases. (B) Posterior regions from stage XI-XIV pregastrula embryos or anterior lateral (precardiac) mesendoderm from stage 5 gastrula embryos was excised and explanted directly into 100 ng/ml follistatin or conditioned medium containing noggin, cultured for 72 or 48 h, respectively, and assayed for the presence of cardiac myocytes. An asterisk (*) denotes a value significantly different from control (P Ͻ 0.05).
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Activin/TGF␤ Signaling Acts Upstream of BMP Signaling in the Cardiac Myogenesis Pathway
Several lines of evidence indicate that activin/TGF␤ signaling lies upstream of BMP-2/ BMP-4 signaling in the cardiac myogenesis pathway. First are the reciprocal inducing capacities of hypoblast versus anterior lateral endoderm and of the ligands that have been localized to each cell layer (activin/TGF␤ and BMP-2, respectively). Activin induces cardiac myogenesis in pregastrula epiblast (Yatskievych et al., 1997 , and this paper), but is unable to induce heart muscle cells in gastrula-stage anterior lateral mesoderm (Schultheiss et al., 1997) , posterior lateral mesoderm (Fig.  2B) , or posterior primitive streak (T.A.Y., A.N.L., and P.B.A., unpublished observations). The ability of activin to instructively induce cardiac myogenesis in epiblast, but not in mesoderm derived from epiblast, mimics the activity of pregastrula hypoblast (Yatskievych et al., 1997) and is consistent with the localization of activin ␤ mRNAs to the chick pregastrula hypoblast (Mitrani et al., 1990) . TGF␤ proteins have been detected in scattered cells of the hypoblast and in marginal zone cells of the pregastrula chick embryo (Sanders et al., 1994) , and TGF␤-1 can likewise substitute for the hypoblast to induce cardiac myogenesis in epiblast. Activin and TGF␤ also have similar mesoderm-inducing activities in amphibian assays (Rosa et al., 1988; Green et al., 1992; Logan and Mohun, 1993) and act through common intracellular transducers, the Mad proteins. Binding of TGF␤ or activin to its receptor triggers phosphorylation and nuclear translocation of Smad2 in Xenopus and human (Graff et al., 1996; Nakao et al., 1997) , revealing an intersection of their signaling pathways downstream of ligand binding. TGF␤s have also been . Posterior region epiblast from pregastrula chick embryos was explanted into control conditioned medium (A, B), control conditioned medium containing 5 ng/ml activin (C, D), or conditioned medium containing noggin plus 5 ng/ml activin (E, F), cultured for 72 h, and assayed for the presence of cardiac myocytes. Noggin blocks the ability of activin to induce myocardial cell formation in epiblast.
shown to modulate levels of activin mRNA expression in cultured embryonal cells (van der Kruijssen et al., 1993) . It is therefore possible that TGF␤-1 induces cardiac myogenesis in epiblast by upregulation of activin expression. Alternatively, TGF␤ and activin may have redundant or overlapping inductive roles in the cardiac myogenesis pathway.
BMP-2 or BMP-4, in contrast, readily induces cardiac muscle markers in gastrula-stage anterior medial meso- Stage XI-XIV posterior region explants from chick blastoderms were explanted in control medium. Treatment was initiated at varying times following explantation by replacement of control medium with medium containing 100 ng/ml BMP-2 or 10 ng/ml BMP-4, and the incidence of cardiac myogenesis was determined following 72 h of culture. (B) Posterior regions from stage XI-XIV pregastrula embryos, primitive-streak heart-forming regions of stage 2-3 early to midgastrula, or anterior lateral (precardiac) mesendoderm from stage 5 late gastrula embryos were excised and explanted directly into 100 ng/ml BMP-2 or 10 ng/ml BMP-4, cultured for 72 or 48 h, respectively, and assayed for the presence of cardiac myocytes. An asterisk (*) denotes a value significantly different from control (P Ͻ 0.05).
FIG. 7.
Multistep signaling model of cardiac myogenesis. (A) Prior to gastrulation (stage XIII), BMP-4 is broadly expressed in the epiblast, while activin and TGF␤ are expressed in pregastrula hypoblast. Antagonism of BMP-4 activity by chordin in posterior epiblast cells leads to the onset of gastrulation (Streit et al., 1998) . Reduced heart muscle-inducing capacity of anterior relative to posterior hypoblast (Yatskievych et al., 1997) may reflect an anterior to posterior expression gradient of activin/TGF␤ or related molecules. (B) Specification of myocardial precursors (specified cells shown in red) appears to commence at stage 3 while cells fated to form heart are within the primitive streak in a broad region posterior to Hensen's node. BMP-2 is expressed in the posterior streak at this stage. Based upon analogy 416 Ladd, Yatskievych, and Antin derm (Schultheiss et al., 1997; Andrée et al., 1998) and when combined with FGF-4 can induce myocardial cell formation in stage 5-6 posterior lateral mesoderm ( Fig. 2B ; Lough et al., 1996) . Data presented here show that BMP-2 or BMP-4, alone or in combination with FGF-4, fails to induce cardiac myogenesis in epiblast. BMPs, with FGF-4, can thus mimic anterior lateral endoderm, which can convert mesoderm to myocardial lineages but has essentially no capacity to induce epiblast cells to form heart muscle (Yatskievych et al., 1997) . This is consistent with the localization of BMP-2 and FGF-4 in the endoderm and BMP-4 in the ectoderm adjacent to precardiac mesoderm at gastrula stages (Sugi and Lough, 1995; Schultheiss et al., 1997; Andrée et al., 1998) and with the localization of Smad1 and Smad5, the intracellular mediators of BMP signaling (Yamamoto et al., 1997) . Chicken Smad1 and Smad5 are expressed during early gastrula stages within cells of the primitive streak (L. Gont and J. Lough, personal communication) at the time when endoderm and mesoderm first appear and myocardial cell specification commences (Yatskievych et al., 1997) .
Additional evidence that activin/TGF␤ signaling lies upstream of BMP signaling in the cardiac myogenesis pathway was obtained using noggin and follistatin. Noggin, a specific antagonist of BMP signaling (Piccolo et al., 1996; Zimmerman et al., 1996) , continued to block cardiac myogenesis in intact (epiblast plus hypoblast) posterior regions until administration was delayed 36 h following explantation, a time very close to the onset of differentiation in vitro (Yatskievych et al., 1997) . Follistatin, which antagonizes activin with 10-fold greater efficacy than BMP activity (Nakamura et al., 1990; Kogawa et al., 1991; Yamashita et al., 1995; Fainsod et al., 1997) , blocked appearance of cardiac myocytes only when added up to 24 h following explantation. These results reflect differences in vivo; noggin, but not follistatin, repressed appearance of myocardial cells in stage 5 precardiac region explants. This repression was lost by stage 6, consistent with previously published reports (Schultheiss et al., 1997) . Noggin was also shown to inhibit induction of cardiac myogenesis in epiblast by activin, providing additional evidence that BMP signaling is required downstream of activin signaling in the cardiac myogenesis pathway. Taken together with the reciprocal inducing capacities of activin/TGF␤ and BMP-2/BMP-4, our results support a model of cardiogenesis in which these molecules mediate temporally and qualitatively distinct signals derived from pregastrula hypoblast acting on epiblast and endoderm acting on emerging mesoderm, respectively.
BMPs May Play a Dual Role in Determining Myocardial Cell Fate
In addition to the inductive role for BMP-2/BMP-4 acting on the mesoderm in the cardiac myogenesis pathway, BMPs also play an early inhibitory role in the epiblast. BMP-2 mRNA is detectable by RT-PCR in the chick embryo just prior to gastrulation (Andrée et al., 1998) , and BMP-4 is expressed broadly in the epiblast of the pregastrula chick embryo (Streit et al., 1998) . Chordin, a natural BMP antagonist (Piccolo et al., 1996) , is expressed in the region where the primitive streak forms and in Hensen's node as gastrulation proceeds (Streit et al., 1998) . Ectopic expression of chordin in anterior epiblast can induce a secondary primitive streak to form, and overexpression of BMP-4 can inhibit endogenous streak formation (Streit et al., 1998) , demonstrating that repression of BMP signaling is both necessary and sufficient for streak formation. This is consistent with our results showing that BMP-2 or BMP-4 can block the ability of FGF-4, activin, or the hypoblast to induce formation of cardiac myocytes in posterior region epiblast and in heart-forming-region explants prior to stage 3.
A Signaling Cascade Regulating Cardiac Myogenesis
These findings and other published studies suggest a cascade leading from pregastrula epiblast to differentiated myocardium that involves at a minimum the following signaling interactions (Fig. 7): (1) antagonism of BMP-4 expression in epiblast by chordin in the posterior region to initiate gastrulation; (2) induction and patterning of emerging mesoderm prior to stage 4 by activin/TGF␤ dorsalizing signals, likely acting in opposition to BMP signals from posterior primitive streak regions (Schultheiss et al., 1997; Andrée et al., 1998) ; and (3) localized expression of BMP-2 in an anterior arc of endoderm that induces expression of genes such as cNkx2-5 and GATA-4 in overlying mesoderm during later gastrula stages, leading to cardiac myocyte differentiation.
to studies in amphibians, posterior BMP-2 expression may oppose anterior signals, perhaps from Hensen's node, to generate an anterior-posterior gradient within emerging mesoderm. While activin/TGF␤ may act as the anterior signaling molecules, their localization within the embryo at this stage is unclear. Anteriorward migration of the hypoblast during gastrulation may also play a role in generating anterior-posterior polarity in mesoderm. Anterior-posterior polarity may reflect direct activation of lineage-specific genes within emerging mesoderm or alternatively may enable cells to respond differentially to later signals from endoderm. (C) By stage 6, precardiac mesoderm has migrated to an anterior lateral position that is directly subtended by endoderm expressing BMP-2, which is required for activation of genes such as cNkx2-5 and GATA-4. Additional molecules produced by the endoderm include IGF-II; insulin; FGFs 1, 2 alt-2, and 4; activin; and vitamin A binding proteins (Barron et al., 1998) . While one or more FGFs may play an inductive role in cardiac myogenesis (this paper and Lough et al., 1996) , other growth factors may stimulate survival and/or replication of precardiac mesoderm. Signals from axial structures, likely including chordin produced by the notochord, are known to inhibit cardiac myogenesis and may help to define the heart morphogenetic field. Abbreviation: HN; Hensen's node.
How do these multiple signaling processes interact to establish the cardiogenic field? It is not clear whether activin/TGF␤ and BMP signals proposed in step (2) above would merely impart polarity to emerging mesoderm or activate genes within specific mesodermal lineages. Activin can induce progressively more dorsal mesodermal derivatives in a dose-dependent manner in both birds and amphibians (Gurdon et al., 1994; Stern et al., 1995; Jones et al., 1996; Jones and Smith, 1998) , and a recent study in Xenopus has shown that genes reflecting different types of mesoderm are differentially expressed based upon the absolute number of occupied activin receptors on responsive cells (Dyson and Gurdon, 1998) . Activin is antagonized by ventral BMP signaling in Xenopus (Candia et al., 1997; Fainsod et al., 1997) , resulting in the graded reappearance of mesoderm along a dorsal-ventral axis. It has been proposed that activation of the opposing activin and BMP signaling pathways results in competition for Smad4, the synergistic partner required for Smad activity (Lagna et al., 1996; Shi et al., 1997) , by the downstream transducers, Smad2 and Smad1/5, respectively (Candia et al., 1997) . This competition could therefore determine the relative strengths and antagonisms of activin/TGF␤ and early BMP signals, leading to the specification of particular cell fates. If activin/ TGF␤ and BMP signaling gradients directly activate genes within specific mesodermal lineages in birds and mammals, this would suggest that cardiac lineage-specific genes are expressed upstream of cNkx2-5, prior to the migration of precardiac mesoderm to anterior lateral regions at stage 5 ϩ -6. Expression of these unknown genes could account for the observations that specification of cardiogenic mesoderm is under way by stage 3 (Yatskievych et al., 1998) and possesses atrial or ventricular identity shortly after emerging from the primitive streak (Yutzey et al., 1995) . Alternatively, patterning of emerging precardiac mesoderm might be reflected in differential responsiveness to a seemingly homogeneous BMP-2 source from the anterior lateral endoderm. Further dissection of these molecular pathways should help distinguish between these possibilities.
